日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03

纳武利尤单抗联合伊匹木单抗对比卡培他滨作为新辅助化疗后残留病灶的三阴性乳腺癌患者术后治疗:一项多中心、随机、开放标签的II期试验 - BREASTIMMUNE-03

Trédan, Olivier; Loirat, Delphine; Chabaud, Sylvie; Toussaint, Philippe; Petit, Thierry; Viret, Frédéric; Levy, Christelle; Robert, Aurélien; Grenier, Julien; Mansi, Laura; Spano, Jean-Philippe; Patsouris, Anne; Derbel, Olfa; Jouannaud, Christelle; Ferrero, Jean Marc; Frenel, Jean Sébastien; Molin, Yann; Doublet, Louis; Heudel, Pierre-Etienne; Pierga, Jean-Yves; Garin, Gwenaële; Pérol, David; Bachelot, Thomas

A Rac-specific competitive inhibitor of guanine nucleotide binding reduces metastasis in triple-negative breast cancer.

鸟嘌呤核苷酸结合的 Rac 特异性竞争性抑制剂可减少三阴性乳腺癌的转移

Dilasser Florian, Rose Lindsay, Quemener Agnès, Ferrandez Yann, Hassoun Dorian, Rousselle Morgane, Bergereau Hugo, Lambot Séverine Marionneau, Anselmino Luciano E, Trouillet Camille, Andre Gwennan, Maillasson Mike, Croyal Mikael, Riviere Matthieu, Dubreuil Didier, Collet Sylvain, Souaze Frédérique, Campone Mario, Patsouris Anne, Mortier Erwan, Marquez Mauricio Menacho, Juin Philippe, Lebreton Jacques, Tessier Arnaud, Cherfils Jacqueline, Loirand Gervaise, Sauzeau Vincent

Real-world analysis of HER2-ultralow in HR+/HER2- metastatic breast cancer: prevalence and first-line chemotherapy outcomes

HER2超低表达在HR+/HER2-转移性乳腺癌中的真实世界分析:患病率和一线化疗结果

Mathiot, Laurent; Kerdraon, Olivier; Le Borgne, Florent; Verriele, Véronique; Patsouris, Anne; Robert, Marie; Chetritt, Jérôme; Loussouarn, Delphine; Campone, Mario; Bocquet, François; Frenel, Jean-Sébastien

Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer

在接受曲妥珠单抗-德鲁西替康治疗后,图卡替尼联合治疗ERBB2阳性转移性乳腺癌患者

Frenel, Jean-Sebastien; Zeghondy, Jean; Guérin-Charbonnel, Catherine; Mailliez, Audrey; Volant, Elsa; Poumeaud, François; Patsouris, Anne; Arnedos, Monica; Bailleux, Caroline; Cabal, Julie; Galland, Loick; de Nonneville, Alexandre; Guiu, Séverine; Dalenc, Florence; Pistilli, Barbara; Bachelot, Thomas; Pierga, Jean-Yves; Le Du, Fanny; Bocquet, François; Larrouquere, Louis; Loirat, Delphine

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane

p4EBP1染色可预测接受依维莫司和依西美坦治疗的ER阳性内分泌耐药转移性乳腺癌患者的预后

Vanacker, Hélène; Treilleux, Isabelle; Schiffler, Camille; Bieche, Ivan; Campone, Mario; Patsouris, Anne; Arnedos, Monica; Cottu, Paul H; Jacquin, Jean-Philippe; Dalenc, Florence; Pinton, Antoine; Servant, Nicolas; Attignon, Valéry; Rouleau, Etienne; Morel, Alain; Legrand, François; Jimenez, Marta; Andre, Fabrice; Bachelot, Thomas

Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program

在法国早期准入计划中,阿特珠单抗和紫杉醇作为一线疗法用于晚期三阴性乳腺癌患者。

de Moura, Alexandre; Vuagnat, Perrine; Renouf, Benjamin; Pierga, Jean-Yves; Loirat, Delphine; Vaflard, Pauline; Lafayolle de la Bruyère, Charline; Chaumard-Billotey, Natacha; Hajjaji, Nawale; Ladoire, Sylvain; Dabakuyo, Sandrine; Patsouris, Anne; Frenel, Jean Sébastien; Nicolai, Vincent; Alexandre, Marie; Dohollou, Nadine; Grenier, Julien; Bourien, Heloïse; Bidard, François-Clément

Intrathecal Catheter for Chemotherapy in Leptomeningeal Carcinomatosis From HER2-Negative Metastatic Breast Cancer

用于治疗HER2阴性转移性乳腺癌引起的软脑膜癌的鞘内化疗导管

Dupoiron, Denis; Autier, Lila; Lebrec, Nathalie; Seegers, Valérie; Folliard, Caroline; Patsouris, Anne; Campone, Mario; Augereau, Paule

Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France

法国ERBB2低表达与ERBB2零表达转移性乳腺癌的治疗及预后比较

de Calbiac, Ombline; Lusque, Amélie; Mailliez, Audrey; Bachelot, Thomas; Uwer, Lionel; Mouret-Reynier, Marie-Ange; Emile, George; Jouannaud, Christelle; Gonçalves, Anthony; Patsouris, Anne; Diéras, Véronique; Leheurteur, Marianne; Petit, Thierry; Cottu, Paul; Ferrero, Jean-Marc; D'Hondt, Véronique; Desmoulins, Isabelle; Mourato-Ribeiro, Joana; Martin, Anne-Laure; Frenel, Jean-Sébastien

Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations

HER2阴性转移性乳腺癌患者接受铂类和非铂类一线化疗后的预后,以及携带和不携带致病性生殖系BRCA1/2突变患者的预后

Jacot, William; Lusque, Amélie; Vicier, Cécile; Mailliez, Audrey; de La Motte Rouge, Thibault; Cabel, Luc; Levy, Christelle; Patsouris, Anne; Desmoulins, Isabelle; Uwer, Lionel; Thery, Jean-Christophe; Robain, Mathieu; Caron, Olivier; Tredan, Olivier; Filleron, Thomas; Frenel, Jean-Sébastien; Delaloge, Suzette

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer

基线 [(18)F]FDG PET/CT 代谢、体积和纹理参数在早期三阴性乳腺癌中的预后价值

Bouron, Clément; Mathie, Clara; Seegers, Valérie; Morel, Olivier; Jézéquel, Pascal; Lasla, Hamza; Guillerminet, Camille; Girault, Sylvie; Lacombe, Marie; Sher, Avigaelle; Lacoeuille, Franck; Patsouris, Anne; Testard, Aude